| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/28/2004 | CA2424003A1 Anti-microbial topical composition comprising alcohol and chlorhexidine salt |
| 09/28/2004 | CA2224125C Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 09/28/2004 | CA2167268C Anti-angiogenic compositions and methods of use |
| 09/23/2004 | WO2004081039A1 Novel protein and its dna |
| 09/23/2004 | WO2004080999A1 Pyrazole compounds useful in the treatment of inflammation |
| 09/23/2004 | WO2004080488A2 Combined preparations of acetyl salicylic acid with an hmg-coa reductase inhibitor |
| 09/23/2004 | WO2004080485A1 Preventive/remedy for diseases in upper digestive tract |
| 09/23/2004 | WO2004080482A2 Use of angiotensin converting enzyme (ace) inhibitors to prevent diabetes in a subject with chronic heart failure |
| 09/23/2004 | WO2004080481A1 Novel nph insulin preparations |
| 09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | WO2004080474A1 Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising prenyl flavonoids |
| 09/23/2004 | WO2004080468A1 Improved bioavailability and improved delivery of alkaline pharmaceutical drugs |
| 09/23/2004 | WO2004080467A2 Method of treating and preventing hyperparathyroidism with vitamin d2 or d4 compounds |
| 09/23/2004 | WO2004080446A1 Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine |
| 09/23/2004 | WO2004080445A1 Methods and compositions for the treatment of cancer |
| 09/23/2004 | WO2004080443A1 Treatment and/or prevention of non-viral epithelial damage |
| 09/23/2004 | WO2004080437A1 Method of delivering substance by transdermal absorption, peeling agent to be used in delivery of substance by transdermal absorption, peeling apparatus and disposable pad for peeling apparatus |
| 09/23/2004 | WO2004080429A2 Use of thiol-based compositions in ameliorating mucosal injury |
| 09/23/2004 | WO2004080414A2 Composition and method for treating inflammations by reducing c-reactive protein |
| 09/23/2004 | WO2004080408A2 Method of treating cancer with azaspirane compositions |
| 09/23/2004 | WO2004080401A2 Oral insulin therapies and protocol |
| 09/23/2004 | WO2004080393A2 Selective cytokine inhibitory drugs for treating disorders of the central nervous system |
| 09/23/2004 | WO2004072027A3 Chemical derivatives binding very specifically with g-quadruplex dna structures and use thereof as a specific anti-cancer agent |
| 09/23/2004 | WO2004069156A3 Inactivated probiotic bacteria and methods of use thereof |
| 09/23/2004 | WO2004069150A3 Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of cholesterol and triglycerides |
| 09/23/2004 | WO2004067022A3 Use of a mixture containing neuropeptides and steroids for treating disturbances of psychosocial experiences and behaviour |
| 09/23/2004 | WO2004064845A8 Compositions and methods for combination antiviral therapy |
| 09/23/2004 | WO2004060348A3 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium |
| 09/23/2004 | WO2004058353A3 Therapeutic use of selective noradrenaline reuptake inhibitors |
| 09/23/2004 | WO2004058269A9 Use of gnrh agonists to support the luteal phase during infertility treatment |
| 09/23/2004 | WO2004056320A3 Compositions of non-steroidal anti-inflammatory drugs decongestants and anti-histamines |
| 09/23/2004 | WO2004052296A3 Dioxolane thymine and combinations for use against 3tc/ azt resistant strains of hiv |
| 09/23/2004 | WO2004030684A3 Kavalactone product |
| 09/23/2004 | WO2004018710A3 Diagnosis of chronic rejection |
| 09/23/2004 | WO2004014293A3 Combination of anti-muscarinic agents and non-glucocorticoid steroids |
| 09/23/2004 | WO2003094836A3 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 09/23/2004 | WO2003087815A3 Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein |
| 09/23/2004 | WO2003063782A3 Kappa-pviia-related conotoxins as organ protectants |
| 09/23/2004 | US20040186587 Devices and methods for treating tissue |
| 09/23/2004 | US20040186295 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders |
| 09/23/2004 | US20040186275 Sarcomere binding polypeptide for use in diagnosis and treatment of diabetes and cardiomyopathies; diuretics; vasodilation; antiarrhythmic agents |
| 09/23/2004 | US20040186273 Prion-binding ligands and methods of using same |
| 09/23/2004 | US20040186185 Method for treatment and chemoprevention of prostate cancer |
| 09/23/2004 | US20040186184 Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
| 09/23/2004 | US20040186183 Anti-infective compositions, methods and systems for treating pathogen-induced disordered tissues |
| 09/23/2004 | US20040186182 Creating local analgesic effect without burning sensation; coadministering with sodium channel blocker to discrete painful site |
| 09/23/2004 | US20040186177 treating a disorder selected from obsessive compulsive disorder (OCD), agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, post traumatic stress syndrome (PTSD), restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia |
| 09/23/2004 | US20040186175 Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 09/23/2004 | US20040186164 Pharmaceutical composition comprising citrulline |
| 09/23/2004 | US20040186163 Novel combination |
| 09/23/2004 | US20040186159 used to treat glaucomatous optic neuropathy and/or lower and control intraocular pressure (IOP) associated with normal-tension glaucoma, ocular hypertension, and/or glaucoma in warm blooded animals, including man |
| 09/23/2004 | US20040186155 Combination therapy for the treatment or prevention of migraine |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186130 Delivery of muscle relaxants through an inhalation route |
| 09/23/2004 | US20040186124 Anticarcinogenic agents, antitumor agents treating cancer of breast, head , neck, gastrointestinal or stomach, leukemia, ovaries, bronchi, lung or pancreas |
| 09/23/2004 | US20040186121 Tamper-resistant oral opioid agonist formulations |
| 09/23/2004 | US20040186099 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 09/23/2004 | US20040186086 Estetrol and estetrol-like substances have relatively low estrogenic potency, metabolic stability, long half-life; triene steroids |
| 09/23/2004 | US20040186083 Combination of an aldosterone receptor antagonist and an endothelin receptor antagonist and/or endothelin converting enzyme inhibitor |
| 09/23/2004 | US20040186082 Applying a vitamin D precursors followed by exposure to ultraviolet radiation or blue light; calcitriol and calcitriol analog precursors, NFkappaB inhibitors, vitamin D receptor stimulants and/or photosensitizers |
| 09/23/2004 | US20040186052 Administering to a patient suffering from neurological disorder a therapeutically effective amount of an RDP-58 peptide |
| 09/23/2004 | US20040186049 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 09/23/2004 | US20040186048 Gene regulation therapy involving ferritin |
| 09/23/2004 | US20040186045 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/23/2004 | US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 09/23/2004 | US20040185508 Methods and reagents for modulating cholesterol levels |
| 09/23/2004 | US20040185507 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 09/23/2004 | US20040185497 Method and kit for the screening, the detection and/or the quantification of transcriptional factors |
| 09/23/2004 | US20040185489 Gene transcription assay method |
| 09/23/2004 | US20040185485 Gene markers useful for detecting skin damage in response to ultraviolet radiation |
| 09/23/2004 | US20040185439 using polymorphisms to determine susceptibility cancer, osteoporosis, cardiovascular disorders; for drug screening |
| 09/23/2004 | US20040185433 such as acyclovir/valaciclovir or penciclovir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in the treatment and/or prevention |
| 09/23/2004 | US20040185122 Selective COX-2 inhibition from edible plant extracts |
| 09/23/2004 | US20040185119 by administering supplemental vitamins; dosage forms such as omeprazole and vitamin B12 |
| 09/23/2004 | US20040185117 Cephalotaxine alkaloid compositions and uses thereof |
| 09/23/2004 | US20040185104 Biodegradable and water soluble polyesterether block polymers possessing reverse thermal gelation properties, used for drug delivery of genes, peptides, anticancer or antiproliferative agents |
| 09/23/2004 | US20040185100 Dosage form with two regions, an extended release region of an NSAID such as diclofenac and an immediate release gastroprotective prostaglandin; osteoarthritis or rheumatoid arthritis; allowing a one a day or twice a day dosing into humans; packaging to minimize oxygen permeation |
| 09/23/2004 | US20040185077 Applying dimethylaminoethanol, tyrosine, and sulfur compound such as lipoic acid, glutathione, sulfur, resorcinol, resorcinol monoacetate, and/or sulfacetamide; skin sensitivity; side effect reduction |
| 09/23/2004 | US20040185076 Treatment of acne using alkonolamine compositions |
| 09/23/2004 | US20040185067 Material delivery method by skin absorption, peeling agent used for material delivery by skin absorption, peeling device, and disposable pad for peeling device |
| 09/23/2004 | US20040185065 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 09/23/2004 | US20040185048 Modulation of IL-2- and IL-15-mediated T cell responses |
| 09/23/2004 | US20040185032 enhanced development of prebiotic gastrointestinal ecology in patients with co-morbid diseases which exhibit problems secondary to impaired gastrointestinal health |
| 09/23/2004 | US20040185014 comprises chamomile, lemon balm, passion flower, valerian, and melatonin |
| 09/23/2004 | US20040185009 Composition and device for treating periodontal diseases |
| 09/23/2004 | US20040185008 Delivery of compounds for the treatment of parkinsons through an inhalation route |
| 09/23/2004 | US20040185007 heating layers containing drugs such as benztropine, pergolide, ropinirole, amantadine and deprenyl on solid supports, to produce vapors, then condensing to aerosols which can be delivered by breathing; drug delivery method and devices |
| 09/23/2004 | US20040185006 Delivery of stimulants through an inhalation route |
| 09/23/2004 | US20040185005 Condensation aerosol as doage forms, is produced by heating a thin layer containing of dolasetron, granisetron or metoclopramide to form vapor, condense into an aerosol; fast producing peak plasma concentrations |
| 09/23/2004 | US20040185004 Delivery of erectile dysfunction drugs through an inhalation route |
| 09/23/2004 | US20040185002 condensation aerosol for delivery of a drug selected from chlordiazepoxide, betahistine, clonidine, testosterone, a conjugated estrogen, an estrogen ester, estradiol, an estradiol ester, ethinyl estradiol, an ethinyl estradiol ester and hyoscyamine |
| 09/23/2004 | US20040185001 Delivery of physiologically active compounds through an inhalation route |
| 09/23/2004 | US20040185000 Delivery of antihistamines through an inhalation route |
| 09/23/2004 | US20040184999 Delivery of anti-migraine compounds through an inhalation route |
| 09/23/2004 | US20040184998 Delivery of drug esters through an inhalation route |
| 09/23/2004 | US20040184997 volatilizing a coating of drug on a solid support, having the surface texture of a metal foil, to a temperature sufficient to produce a heated vapor of drug and condensing the heated vapor to form condensation aerosol particles |
| 09/23/2004 | US20040184996 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 09/23/2004 | DE10351648A1 Synergistic drug combination for primary prevention of cardiovascular disease, especially in high-risk patients, comprising acetylsalicylic acid, HMG-CoA and optionally antihypertensive agent |
| 09/23/2004 | CA2518763A1 Treatment and/or prevention of non-viral epithelial damage |